Cargando…

Cell-Mediated Immune Predictors of Vaccine Effect on Viral Load and CD4 Count in a Phase 2 Therapeutic HIV-1 Vaccine Clinical Trial

BACKGROUND: In a placebo-controlled trial of the peptide-based therapeutic HIV-1 p24(Gag) vaccine candidate Vacc-4x, participants on combination antiretroviral therapy (cART) received six immunizations over 18 weeks, followed by analytical treatment interruption (ATI) between weeks 28 and 52. Cell-m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yunda, Pantaleo, Giuseppe, Tapia, Gonzalo, Sanchez, Brittany, Zhang, Lily, Trondsen, Monica, Hovden, Arnt-Ove, Pollard, Richard, Rockstroh, Jürgen, Ökvist, Mats, Sommerfelt, Maja A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652289/ https://www.ncbi.nlm.nih.gov/pubmed/28970080 http://dx.doi.org/10.1016/j.ebiom.2017.09.028

Ejemplares similares

Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption
por: Rockstroh, Jürgen K., et al.
Publicado: (2019)

The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study
por: Brekke, Kristin, et al.
Publicado: (2017)

Influenza: the virus and prophylaxis with inactivated influenza vaccine in “at risk” groups, including COPD patients
por: Hovden, Arnt-Ove, et al.
Publicado: (2007)

Quality of T-cell responses versus reduction in viral load: results from an exploratory phase II clinical study of Vacc-4x, a therapeutic HIV vaccine
por: Ellefsen-Lavoie, K, et al.
Publicado: (2012)

Expression of ESE-3 Isoforms in Immunogenic and Tolerogenic Human Monocyte-Derived Dendritic Cells
por: Sprater, Florian, et al.
Publicado: (2012)

A pilot study of the immune response to whole inactivated avian influenza H7N1 virus vaccine in mice
por: Hovden, Arnt‐Ove, et al.
Publicado: (2009)

The Bacterial Preparation OK432 Induces IL-12p70 Secretion in Human Dendritic Cells in a TLR3 Dependent Manner
por: Hovden, Arnt-Ove, et al.
Publicado: (2012)

Maturation of monocyte derived dendritic cells with OK432 boosts IL-12p70 secretion and conveys strong T-cell responses
por: Hovden, Arnt-Ove, et al.
Publicado: (2011)

Viral vector vaccines
por: McCann, Naina, et al.
Publicado: (2022)

No changes on viral load and CD4+ T-cell counts following immunization with 7-valent pneumococcal conjugate vaccine among HIV-infected adults in Malawi
por: Ibarz-Pavon, A.B., et al.
Publicado: (2018)

Estimating Vaccine Efficacy Against Transmission via Effect on Viral Load
por: Kennedy-Shaffer, Lee, et al.
Publicado: (2021)

Calculated Globulin Adds Predictive Value to Hepatitis B Vaccine Response in HIV-infected Persons Independently of HIV Viral load and CD4 Cell Count
por: O’Bryan, Thomas, et al.
Publicado: (2017)

Third COVID-19 vaccine dose boosts antibody function in Rwandans with high HIV viral load
por: Swan, Cynthia L., et al.
Publicado: (2023)

Influence of the Delta Variant and Vaccination on the SARS-CoV-2 Viral Load
por: Migueres, Marion, et al.
Publicado: (2022)

VACCINATIONS | Viral
por: Olszewska, W., et al.
Publicado: (2006)

Viral Vaccines
por: Schleiss, M.R.
Publicado: (2022)

Effect of the bivalent HPV vaccine on viral load of vaccine and non-vaccine HPV types in incident clearing and persistent infections in young Dutch females
por: van der Weele, Pascal, et al.
Publicado: (2019)

European Medicines Agency extension of indication to include the combination immunotherapy cancer drug treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) for adults with intermediate/poor-risk advanced renal cell carcinoma
por: Ali, Sahra, et al.
Publicado: (2020)

Assessment of HTLV-I proviral load, HIV viral load and CD4 T cell count in infected subjects; with an emphasis on viral replication in co-infection
por: Rahimi, Hossein, et al.
Publicado: (2014)

Vaccine-Associated Enhanced Viral Disease: Implications for Viral Vaccine Development
por: Halstead, Scott B.
Publicado: (2021)

TTV viral load as a predictor of antibody response to SARS COV-2 vaccination
por: Focosi, Daniele, et al.
Publicado: (2023)

Transmissible Viral Vaccines
por: Bull, James J., et al.
Publicado: (2018)

Inactivated Viral Vaccines
por: Sanders, Barbara, et al.
Publicado: (2014)

Respiratory Viral Vaccines
por: Schmid, D. Scott, et al.
Publicado: (2005)

The Effect of GBV-C Infection on CD4 Count and Viral Loads in Patients Infected With HIV
por: Keyvani, Hossein, et al.
Publicado: (2012)

Vaccination reduces viral load and accelerates viral clearance in SARS-CoV-2 Delta variant-infected patients
por: Li, Hongxia, et al.
Publicado: (2023)

Development of an enterotoxigenic Escherichia coli vaccine based on the heat-stable toxin
por: Zegeye, Ephrem Debebe, et al.
Publicado: (2018)

Discovery medicine – the HVTN's iterative approach to developing an HIV-1 broadly neutralizing vaccine
por: Martin, Troy M., et al.
Publicado: (2023)

Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers
por: Marking, Ulrika, et al.
Publicado: (2023)

Vaccine effectiveness in symptom and viral load mitigation in COVID-19 breakthrough infections in South Korea
por: Jang, Jieun, et al.
Publicado: (2023)

Implementation of EACS vaccination recommendations among people living with HIV
por: Breitschwerdt, Sven, et al.
Publicado: (2022)

Preliminary X-ray crystallographic analysis of the secreted chorismate mutase from Mycobacterium tuberculosis: a tricky crystallization problem solved
por: Krengel, Ute, et al.
Publicado: (2006)

Managing Everyday Life: A Qualitative Study of Patients’ Experiences of a Web-Based Ulcer Record for Home-Based Treatment
por: Trondsen, Marianne V.
Publicado: (2014)

ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF
por: Durheim, Michael T, et al.
Publicado: (2020)

Altering Compositional Properties of Viral Genomes to Design Live-Attenuated Vaccines
por: Pereira-Gómez, Marianoel, et al.
Publicado: (2021)

Intranasal Administration of a Therapeutic HIV Vaccine (Vacc-4x) Induces Dose-Dependent Systemic and Mucosal Immune Responses in a Randomized Controlled Trial
por: Brekke, Kristin, et al.
Publicado: (2014)

Changing antiretrovirals whilst viral load <50 copies/ml and relationship with CD4 count changes
por: Mocroft, A
Publicado: (2010)

CD4 Counts and Viral Loads of Newly Diagnosed HIV-Infected Individuals: Implications for Treatment as Prevention
por: Govender, Sarishen, et al.
Publicado: (2014)

Cholesterol efflux responds to viral load and CD4 counts in HIV+ patients and is dampened in HIV exposed
por: Tort, Olivia, et al.
Publicado: (2018)

Viral Vaccines and CTL Response
por: Woolard, Stacie N., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_5pgr1krrvnjl1iot90ik0sc11g